Nexsen Overview
About Nexsen
Nexsen Ltd is a nanobiotechnology company for the development of biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications. Its products include: GBS Rapid Sensor, Chronic Kidney Disease (CKD), Bovine Mastitis, Acute Kidney Injury (AKI), and Biosecurity Pathogen Tests (x2).
Founded
N/A
HQ
Employees
N/A
Website
Financials (Last FY)
EV
$15M
Valuation Multiples
Start free trialNexsen Financials
Nexsen P&L
In the most recent fiscal year, Nexsen reported revenue of - and net income of -.
Financial data powered by Morningstar, Inc.
Nexsen Stock Performance
Nexsen has current market cap of $18M, and enterprise value of $15M.
Market Cap Evolution
Nexsen's stock price is $0.09.
Nexsen share price decreased by 22.2% in the last 30 days, and by 21.1% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $15M | $18M | -3.9% | -22.2% | -39.0% | -21.1% | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNexsen Valuation Multiples
Nexsen Financial Valuation Multiples
As of November 19, 2026, Nexsen has market cap of $18M and EV of $15M.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nexsen Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Nexsen Margins & Growth Rates
Nexsen Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Nexsen Competitors
Nexsen competitors include Urteste, Microba Life Sciences, Genedrive, Genematrix, BCAL Diagnostics, Rhythm Biosciences, Read-Gene, IMBdx, Glycorex Transplantation and Bionano Genomics.
Most Nexsen public comparables operate across Diagnostics & Genomics and BioTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $5K | ($1M) | 3204.7x | - | (12.4x) | - | |||
| $10M | ($11M) | 1.6x | 1.5x | (1.4x) | (2.0x) | |||
| $1M | ($7M) | 19.1x | - | (2.7x) | - | |||
| $8M | ($1M) | 1.2x | - | (8.3x) | - | |||
| $123K | ($4M) | 150.9x | 10.0x | (4.3x) | - | |||
| $57K | ($4M) | 215.5x | - | (3.2x) | - | |||
| $4M | $224K | 3.4x | - | 58.5x | - | |||
| $4M | ($5M) | 2.1x | - | (1.6x) | - | |||
This data is available for Pro users. Sign up to see all Nexsen competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nexsen
| Where is Nexsen headquartered? | Nexsen is headquartered in Australia. |
| Is Nexsen publicly listed? | Yes, Nexsen is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Nexsen? | Nexsen trades under NXN ticker. |
| When did Nexsen go public? | Nexsen went public in 2025. |
| Who are competitors of Nexsen? | Nexsen main competitors include Urteste, Microba Life Sciences, Genedrive, Genematrix, BCAL Diagnostics, Rhythm Biosciences, Read-Gene, IMBdx, Glycorex Transplantation, Bionano Genomics. |
| What is the current market cap of Nexsen? | Nexsen's current market cap is $18M. |
| Is Nexsen profitable? | No, Nexsen is not profitable. |
| How many companies Nexsen has acquired to date? | Nexsen hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Nexsen has invested to date? | Nexsen hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Nexsen
Lists including Nexsen
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




